4.2 Article

Antibiotic Resistance: From Darwin to Lederberg to Keynes

Journal

MICROBIAL DRUG RESISTANCE
Volume 19, Issue 2, Pages 73-87

Publisher

MARY ANN LIEBERT, INC
DOI: 10.1089/mdr.2012.0115

Keywords

-

Funding

  1. Bayer
  2. Boehringer-Ingelheim
  3. Stendhal
  4. Pfizer
  5. MSD

Ask authors/readers for more resources

The emergence and spread of antibiotic-resistant bacteria reflects both, a gradual, completely Darwinian evolution, which mostly yields slight decreases in antibiotic susceptibility, along with phenotypes that are not precisely characterized as resistance; and sudden changes, from full susceptibility to full resistance, which are driven by a vast array of horizontal gene transfer mechanisms. Antibiotics select for more than just antibiotic resistance (i.e., increased virulence and enhanced gene exchange abilities); and many non-antibiotic agents or conditions select for or maintain antibiotic resistance traits as a result of a complex network of underlying and often overlapping mechanisms. Thus, the development of new antibiotics and thoughtful, integrated anti-infective strategies is needed to address the immediate and long-term threat of antibiotic resistance. Since the biology of resistance is complex, these new drugs and strategies will not come from free-market forces, or from incentives for pharmaceutical companies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available